The United Nations agency said that “a large amount of clinical research data” shows that Johnson & Johnson’s vaccine is effective for the adult population.
Geneva- The World Health Organization has approved the emergency use of Johnson’s single-dose coronavirus vaccine, which means that the single-shot vaccine can be used for global distribution as part of the international COVAX program, including distribution to poor countries without supplies.
The United Nations agency said in a statement issued today that “a large amount of clinical trial data” shows that the Johnson & Johnson vaccine is effective for adults.
The United Nations Medicines Agency recommends that the vaccine be approved in 27 EU countries before obtaining an emergency use certificate. US federal regulators approved Johnson & Johnson’s vaccine for emergency use last month.
A large-scale study on three continents concluded that the vaccine is 85% effective in preventing serious illness, hospitalization and death. Even in countries with other variants (such as South Africa), this protection is still strong.
The UN-supported COVAX plan has previously announced a preliminary agreement with Johnson & Johnson for 500 million doses, but it is not legally binding.